Research Highlights Cutting-Edge New Treatments for Blood Disorders

/PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches...

Related Keywords

New York ,United States ,Georgetown University ,District Of Columbia ,Washington ,American ,Stephanie Lee ,Franco Locatelli ,Catherine Broome ,Ernestn Morial Convention Center ,Janssen Research Development ,Georgetown Lombardi Cancer Center ,Tisch Cancer Institute At Mount Sinai ,Fred Hutchinson Cancer Center ,Georgetown University School Of Medicine ,American Society Of Hematology ,Receptor Familyc Group ,American Society ,Annual Meeting ,Generates High Response Rate ,Hard To Treat Multiple Myeloma ,Refractory Multiple Myeloma ,Ajai Chari ,Tisch Cancer Institute ,Mount Sinai ,Janssen Research ,Platelet Count Observed ,More Than Half ,Intravenous Efgartigimod ,Primary Immune Thrombocytopenia ,Randomized Clinical Trial ,Georgetown University School ,Undergoing Gene Therapy ,Improved Quality ,Long Term Outcomes ,Gene Therapy ,Exploratory Analysis ,Successful Treatment Outcomes ,